SOLV Solventum Loading...

From TMO earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
08:30
Jan 29 ◎
Mark Casper Chairman, President, and CEO, Thermo Fisher Scientific Inc TMO Q4 FY25 call
Thermo Fisher acquired Solventum's filtration and separation business to extend bioproduction capabilities; Solventum divests a non-core unit for cash.
SOLV
HIGH
08:30
Oct 22 ◎
Mark Masper CEO, Thermo Fisher Scientific Inc TMO Q3 FY25 call
Thermo Fisher adds bioprocessing and industrial filtration capabilities, expanding its addressable market and customer base.
SOLV
HIGH

About SOLV Analyst Coverage

Buzzberg tracks SOLV (Solventum) across 1 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Latest voices: Mark Casper, Mark Masper.